Showing results (1201-1210 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|March 21, 2017
Imaging and clinicopathological features of nivolumab-related cholangitis in patients with non-small cell lung cancerHisato Kawakami, Junko Tanizaki, Kaoru Tanaka, et al.Investigational New Drugs|July 1, 1989
Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: an Illinois Cancer Council StudyD H Shevrin, T E Lad, L J Kilton, et al.Investigational New Drugs|April 9, 2014
Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cellsEsther Z Chen, Blake A Jacobson, Manish R Patel, et al.Investigational New Drugs|April 18, 2014
Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid tumorsBrian A Costello, Mitesh J Borad, Yingwei Qi, et al.Investigational New Drugs|March 15, 2014
Radiosensitizing activity of a novel Benzoxazine through the promotion of apoptosis and inhibition of DNA repairSuraj Radhamani, Christopher Bradley, Terri Meehan-Andrews, et al.Investigational New Drugs|March 18, 2014
Contributions from emerging transcriptomics technologies and computational strategies for drug discoveryOnat Kadioglu, Thomas EfferthInvestigational New Drugs|April 1, 1988
Phase II study of fludarabine phosphate in patients with advanced colorectal carcinomaJ A Ajani, J L Abbruzzese, J S Faintuch, et al.Investigational New Drugs|January 26, 2017
A truncated apoptin protein variant selectively kills cancer cellsSantiago Ruiz-Martínez, Jessica Castro, Maria Vilanova, et al.Investigational New Drugs|July 1, 1989
The effects of the anti-tumor agent mezerein on the cytotoxic capacity and oxidative metabolism of human blood cellsK Barton, G Randall, A L SagoneInvestigational New Drugs|July 1, 1989
Phase II evaluation of gallium nitrate by continuous infusion in breast cancerK Jabboury, D Frye, F A Holmes, et al.Pageof 372